Is Family Care overvalued or undervalued?
As of October 20, 2025, Family Care is considered overvalued with a PE Ratio of 0.81 and an EV to EBITDA of 0.97, significantly higher than peers like Apollo Hospitals and Max Healthcare, and has underperformed the Sensex with a year-to-date return of -33.48%.
As of 20 October 2025, the valuation grade for Family Care has moved from fair to expensive, indicating a shift in its market perception. The company is currently overvalued based on its financial ratios, with a PE Ratio of 0.81, an EV to EBITDA of 0.97, and a ROE of 219.63%. These figures suggest that despite a high return on equity, the overall valuation metrics do not support the current market price.In comparison to its peers, Family Care's valuation appears significantly higher than that of Apollo Hospitals, which has a PE Ratio of 73.21 and an EV to EBITDA of 37.60, while Max Healthcare is categorized as very expensive with a PE Ratio of 97.36. Additionally, Family Care's stock has underperformed the Sensex, with a year-to-date return of -33.48% compared to the Sensex's positive return of 7.97%. This further reinforces the conclusion that Family Care is overvalued in the current market environment.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
